Investor
Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 440 (TSX: $VLNS.TO)
(NASDAQ: $GNLN) (CSE: $CURA.C) (TSX: $HMMJ.TO)
Delta, Kelowna, BC, July 10, 2020 (Investorideas.com Newswire)
www.Investorideas.com, a global news source covering leading sectors including
marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s podcast edition of cannabis news and stocks to watch plus insight
from thought leaders and experts.
Listen to the podcast:
Read this in full
at https://www.investorideas.com/news/2020/cannabis-potcasts/07131VLNS-GNLN-CURA-HMMJ.asp
Today’s podcast overview/transcript:
Good
afternoon and welcome to another episode of Investorideas.com
"Potcast" featuring cannabis news, stocks to watch as well as
insights from thought leaders and experts.
In
today’s podcast we look at a few public and private company announcements.
The
Valens Company Inc. (TSX:
VLNS) (OTCQX:
VLNCF) announced its
participation in a Medical Cannabis Real-World Evidence Study led by Dr. Hance
Clarke of the University Health Network (UHN) in Toronto, Canada. The study
will explore the therapeutic effects of medical cannabis in adults with chronic
pain, sleep, or anxiety issues, and will leverage the blockchain secure
technology of the Medical Cannabis by Shoppers online product portal of both
tested and verified cannabis products.
The Valens Company has contributed
to the study with the inclusion of Nūance, its
exclusive brand of premium cannabis oil developed by the Company for Medical
Cannabis by Shoppers. As part of the study, the Nūance line of THC and CBD oils
will be tested, with the verified results on each batch made available through
the Medical Cannabis by Shoppers portal for each physician and patient.
Patients will be able to identify the contents of their product through the
platform, including potency levels of THC and CBD, and confidently rely on the
data to ensure batch-to-batch consistency and quality. The goal of this study
is to provide physicians, pharmacists, and patients with confidence in medicinal
cannabis products as an alternate treatment for various ailments, including
pain relief.
"Nūance oils are developed
exclusively for Shoppers Drug Mart with medical cannabis patients at the core.
To be able to participate in this real-world study and have the opportunity to
understand how our products could be used as a treatment is an exciting step in
the right direction for us," said Tyler Robson, Chief Executive Officer of
The Valens Company. "With insights and data from this study, we look forward
to further advancing our commitment to developing and testing the
highest-quality and most reliable products for patients using cannabis for both
medical purposes as well as recreational consumers."
"Medical Cannabis by Shoppers
is best placed to offer Canadians the reassurance of medical products that have
been tested and validated," said Ken Weisbrod, Vice President, Business
Development/Cannabis Strategy, Shoppers Drug Mart. "Our development of a
blockchain secured initiative with TruTrace has now been integrated into an
operational portal that will provide products with an immutable digital
identity that can capture everything from detailed chemistry down to its
DNA."
The MC-RWE Study is a prospective,
non-interventional, observational study to describe the benefits of medical
cannabis for various common medical issues and seeks to enroll at least 2,000
subjects from across Canada who will be followed for 24 weeks. More on this
study can be found here.
Greenlane
Holdings, Inc. (NASDAQ:
GNLN), one of the largest global sellers of premium
cannabis accessories, child-resistant packaging, supply, and specialty
vaporization products, announced
today their partnership with NEO Plastics, an innovative packaging company providing an entirely
new sustainable solution for discarded plastics. Available this July
exclusively to Greenlane customers, NEO Packaging adds an
environmentally-friendly offering to Greenlane’s existing packaging lines.
NEO Plastics supports landfill
gas-to-energy efforts to enhance the end-of-life value of plastic packaging.
NEO’s packaging contains an additive that accelerates the natural microbial
digestion of the packaging’s material faster than standard plastic
alternatives. During this process, biogases are released and can be collected
and turned into clean, renewable energy which can be used to power communities.
“Sustainable packaging is in very
high demand in the cannabis industry and we are proud to offer an
environmentally-friendly alternative to our customers,” said Aaron LoCascio,
Co-Founder and CEO of Greenlane Holdings. “NEO Plastics produces innovative and
forward-thinking products that convert waste challenges into energy
opportunities and we are excited to help them on their mission to spread
awareness about the world’s environmental needs.”
NEO Packaging does not change the
feel, form, or function of traditional mylar bags, allowing it to maintain its
high-barrier properties. They are ASTM and CPSC child-resistant compliant with
a concealed child-resistant zipper. The packaging will be available in six
sizes ranging from a gram to a pound and come in two colors. A wide variety of
made-to-order customization capabilities are available, including stateside and
overseas printing and application enhancements. This product line is
competitively priced at or below market prices of traditional mylar barrier
bags.
Curaleaf
Holdings, Inc. (CSE:
CURA) (OTCQX:
CURLF) today
announced that Curaleaf has completed the acquisition from Grassroots of exclusive
rights to the Grassroots' All Rebels Rockers, Inc. marijuana license in
Arizona. The transaction was completed in advance of the closing of Curaleaf's
acquisition of Grassroots to enable accelerated development of the All Rebel
Rockers license.
Curaleaf's acquisition of Grassroots
itself is expected to close early next week, after the Grassroots shareholders
meeting scheduled to approve the revised transaction on July 16.
Joseph Lusardi, CEO of Curaleaf,
said, "Our acquisition of our 9th license in Arizona further strengthens
our presence in the state, which continues to be one of the largest medical
cannabis markets in the country. It also marks one of the final milestones
before we formally close our acquisition of Grassroots."
Under this license Curaleaf will
open its 9th store, as it currently operates eight dispensaries in Arizona and
already has one of the largest retail footprints in the Metro Phoenix Area.
Arizona is one of the largest medical marijuana markets in the U.S. with one of
the highest percentages of registered patients.
The close of the acquisition of
Grassroots will make Curaleaf the world's largest cannabis company by revenue
and the most diversified, vertically integrated cannabis company in the United
States, the world's largest cannabis market. The transaction expands Curaleaf's
presence from 18 to 23 states, with the combined company having over 135
dispensary licenses, 89 operational dispensary locations, over 30 processing
facilities and 22 cultivation sites with 1.6 million square feet of current
cultivation capacity.
Horizons
ETFs Management (Canada) Inc. has completed the quarterly rebalance of
the constituent holdings of the Horizons
Marijuana Life Sciences Index ETF (TSX:
HMMJ) and the Horizons
US Marijuana Index ETF (NEO:
HMUS).
HMMJ seeks to replicate, to the
extent possible, the performance of the North American Marijuana Index, net of
expenses. This index is designed to provide exposure to the performance of a
basket of North American publicly listed life sciences companies with
significant business activities in the marijuana industry. The North American
Marijuana Index selects from a current universe of companies that have
operations that may include one or more offerings of biopharmaceuticals,
medical manufacturing, distribution, bio-products and other ancillary
businesses related to the marijuana industry. Securities within HMMJ's index
generally have a market capitalization of greater than C$75 million.
"Following volatility that
impacted nearly all asset classes across global markets in March, marijuana
companies saw a strong recovery in the first two months of Q2 2020. HMMJ was up
more than 15% for the three months ending at June 30, 2020," said Steve
Hawkins, President and CEO of Horizons ETFs. "While there is volatility
within the marijuana space again, the investing case remains strong: after
Canadian adult-use cannabis sales set new record highs in March they remained
consistently strong into April, reaching over $180 million."
Investor ideas reminds all
listeners to read our disclaimers and disclosures on the Investorideas.com website
and that this podcast is not an endorsement to buy products or services or
securities. Investors are reminded all investment involves risk and possible
loss of investment.
Learn more about
our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
Investorideas.com
podcasts are also available on iTunes,
Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified
word mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
About Investorideas.com - News that
Inspires Big Investing Ideas
Investorideas.com
is a recognized news source publishing third party news, research and original
financial content. Learn about investing in stocks and sector trends with our
news alerts, articles, podcasts and
videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water,
renewable energy and more. Investor Idea’s original branded content includes
the following podcasts and columns : Crypto Corner , Play
by Play sports and stock news column, Investor Ideas
Potcasts Cannabis News and Stocks on the Move podcast and
column, Cleantech
and Climate Change , Exploring
Mining the AI
Eye .
Disclaimer/Disclosure: Investorideas.com is a
digital publisher of third party sourced news, articles and equity research as
well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investing involves risk and possible losses. This site is currently
compensated for news publication and distribution, social media and marketing,
content creation and more. Disclosure is posted for each compensated news
release, content published /created if required but otherwise the news was not
compensated for and was published for the sole interest of our readers and
followers. Contact management and IR of each company directly regarding
specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other
news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations
of each country. Please read Investorideas.com privacy policy
Investor Ideas does not condone the use of
cannabis except where permissible by law. Our site does not possess,
distribute, or sell cannabis products.
Contact Investorideas.com
800
665 0411
No comments:
Post a Comment